Category - Industry news

AGBT 2021 – A Virtual Summary

AGBT 2021 took place virtually this year! But the conference was nevertheless the attention grabber of the week with a twitter storm, active reporting, and several commercial product launches as demonstrated by a slew...read more

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any...read more

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care SALT LAKE CITY, March 02, 2021 (GLOBE NEWSWIRE)...read more

NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Tempus Launches Hereditary Cancer Germline Assay, xG

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

%d bloggers like this:

Category - Industry news

AGBT 2021 – A Virtual Summary

Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services

NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference

Genomics plc completes oversubscribed $30M funding round

WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector

Human Pangenome Reference Consortium Announced Global Release of Year 1 Sequencing Data

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Micronoma Raises $3.5 Million in Convertible Note Financing

Exact Sciences To Acquire Ashion Analytics And Enter Research Collaboration With City Of Hope’s Genomics Institute, TGen

Leading Health Providers Unite to Advance Patient Care by Forming Truveta

Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Tempus Launches Hereditary Cancer Germline Assay, xG

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

Follow Me